Abstract:Ghrelin is a novel 28-amino acid peptide with an n-octanoyl ester in the serine 3 that has recently been discovered in rat and human gastrointestinal tract, as an endogenous ligand for growth hormone (GH) secretagogue receptor 1. Ghrelin is produced and stored in granules of the special neuroendocrine cells (A-like cells), located mainly in oxyntic mucosa 2. Ghrelin stimulates GH release and induces a positive energy balance by stimulating food intake and decreasing fat use 3. Ghrelin also has numerous peripheral actions including direct effects on exocrine and endocrine pancreatic functions, carbohydrate metabolism, gastric secretion, stomach motility, and sleep 4. Recently, some authors revealed that administration of ghrelin during reperfusion had protective effects on myocardial ischemia reperfusion injury, including reduced ischemic volume, improvements in coronary flow, and attenuation of lipid peroxidation in a rat model 5. But the exact effect of ghrelin on focal cerebral ischemia reperfusion and the mechanism underlying it are still unknown. Focal cerebral ischemia in adult male Sprague-Dawley rats (weighing 250–280 g) was induced by MCAO (middle cerebral artery occlusion) for 90 min with an intraluminal filament according to the method previously described by Longa 6. Rat ghrelin was administered intraperitoneally (160 μg/kg) 30 min before MCAO and at the beginning of reperfusion. Brain samples were obtained 24 h after MCAO. In this study, we demonstrated that systemic administration of ghrelin significantly reduced infarct volumes from MCAO (data shown in Figure 1A). The protective effect of ghrelin on cell apoptosis and neuronal degeneration after ischemia reperfusion injury was evaluated by TUNEL and Fluoro-Jade B staining, a kind of polyanionic fluorescein derivative that specifically bound to degenerating neurons. In ghrelin-treated group, the number of TUNEL-positive cells and degenerating neurons in the peri-infarct area decreased significantly (Figure 1B,C). Given the fact that ghrelin can pass through the blood–brain barrier 7, these findings suggest that peripherally administered ghrelin enters the brain parenchyma and exerts neuroprotective effects on cerebral ischemia reperfusion. The inhibitive effect of ghrelin on apoptosis was supposed to be related to the activation of PI3K/AKT signaling pathway by the phosphoralation of Akt in an endothelial cell injury 8. Reactive oxygen species (ROS) have been implicated in the pathogenesis of cerebral ischemia reperfusion injury 9. These oxygen-free radicals are directly toxic to neurons and initiate a free radical-mediated cascade causing neuronal damage. To assess the effect of ghrelin on ROS, we evaluated the production of superoxide anion, an important reactive oxygen species (ROS) using DHE (dihydroethidium). In this study, we found superoxide anion production was enhanced after reperfusion, and ghrelin treatment could attenuate it (Figure 2). These might be related to the mechanism that ghrelin could inhibit NADPH oxidase activation and reduce ROS production 10. In summary, we have demonstrated that peripheral administration of ghrelin could protect neurons from ischemic injury caused by MCAO. The protective effects of ghrelin appear to be related with an inhibition of apoptosis and oxidative stress. Our results suggest that ghrelin can function as a neuroprotective agent, and administration of ghrelin may be a novel therapeutic strategy for the treatment of ischemic stroke. This study was supported by National Natural Sciences Foundation of China (30801183), Key Clinical Disciplines Program of Chinese Health Ministry and Grants of Health Bureau of Zhejiang Province (2012).

Myocardial Angiogenesis After Chronic Ghrelin Treatment In A Rat Myocardial Infarction Model

Raav-Mediated Angiogenin Gene Transfer Induces Angiogenesis and Modifies Left Ventricular Remodeling in Rats with Myocardial Infarction

Angiogenin Gene Transfer Improves Left Ventricular Function in Rats with Myocardial Infarction

Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect.

Expression of Ghrelin and Its Receptor in Rats after Coronary Artery Ligation

Effects of Ghrelin on electrical remodeling in rats with myocardial infarction

Effects of Ghrelin on Cx43 Regulation and Electrical Remodeling after Myocardial Infarction in Rats

Impact of Ghrelin on Ventricular Arrhythmia and Related Mechanism After Myocardial Infarction

A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats

Ghrelin Suppresses Cardiac Fibrosis of Post-Myocardial Infarction Heart Failure Rats by Adjusting the Activin A-follistatin Imbalance

Ghrelin Protects the Myocardium with Hypoxia/reoxygenation Treatment Through Upregulating the Expression of Growth Hormone, Growth Hormone Secretagogue Receptor and Insulin-Like Growth Factor-1, and Promoting the Phosphorylation of Protein Kinase B

Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves.

GHSR-1a is a Novel Pro-Angiogenic and Anti-Remodeling Target in Rats after Myocardial Infarction.

Ghrelin ameliorates cardiac fibrosis after myocardial infarction by regulating the Nrf2/NADPH/ROS pathway

Protective Effects of Ghrelin on Ischemia/reperfusion Injury in the Isolated Rat Heart.

Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice.

Potential new role of the GHSR-1a-mediated signaling pathway in cardiac remodeling after myocardial infarction (Review).

Potential New Role of the GHSR-1a-mediated Signaling Pathway in Cardiac Remodeling after Myocardial Infarction (Review)

Ghrelin Attenuated Cerebral Ischemia Reperfusion Injury in Rats

Inhibition of Endoplasm Reticulum Stress by Ghrelin Protects Against Ischemia/reperfusion Injury in Rat Heart.

Ghrelin Protects Myocardium from Isoproterenol-Induced Injury in Rats